Sight Sciences Stock (NASDAQ:SGHT)

Forecast Revenue Ownership Financials Chart Transcripts

Previous Close

$4.01

52W Range

$2.03 - $9.24

50D Avg

$6.03

200D Avg

$5.12

Market Cap

$199.82M

Avg Vol (3M)

$334.56K

Beta

2.43

Div Yield

SGHT Company Profile

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

216

IPO Date

Jul 15, 2021

Website

SGHT Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/Service	Dec 25	Dec 24	Dec 23
Dry Eye	$1.64M	$3.96M	$6.75M
Surgical Glaucoma	$75.72M	$75.90M	$74.31M

Fiscal year ends in Dec 25 | Currency in USD

SGHT Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	$77.36M	$79.87M	$81.06M
Operating Income	$-37.10M	$-50.53M	$-57.27M
Net Income	$-38.43M	$-51.51M	$-55.55M
EBITDA	$-37.10M	$-45.90M	$-49.41M
Basic EPS	$-0.74	$-1.03	$-1.14
Diluted EPS	$-0.74	$-1.03	$-1.14

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Mar 04, 26 | 4:30 PM

Q3 25Nov 06, 25 | 4:30 PM

Q2 25Aug 08, 25 | 4:30 PM

Peer Comparison

Ticker	Company
SNWV	SANUWAVE Health, Inc.
SENS	Senseonics Holdings, Inc.
QTRX	Quanterix Corporation
CERS	Cerus Corporation
OMI	Owens & Minor, Inc.
MASS	908 Devices Inc.
LFCR	Lifecore Biomedical, Inc.
PRQR	ProQR Therapeutics N.V.
VMD	Viemed Healthcare, Inc.
CVRX	CVRx, Inc.